EconomyEXCLUSIVE: Kimberly-Clark readies asset sales to win EU approval for Kenvue deal, sources say
Kimberly-Clark is preparing concessions, including possible asset sales, to address EU antitrust concerns over its proposed $40 billion purchase of Tylenol maker Kenvue, according to people familiar with the matter. The steps could help secure approval after a preliminary review.
R
EXCLUSIVE: Kimberly-Clark readies asset sales to win EU approval for Kenvue deal, sources say
Economy